More on NAGE
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $3.50 |
|
|||
| Open | $3.51 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $3.55 | ||||
| Day Low | $3.40 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 529,129 | ||||
- Niagen Bioscience to Present at the 16th Annual East Coast IDEAS Investor Conference
- Niagen Bioscience renames research program, cites 300+ collaborations
- Niagen Bioscience Renames ChromaDex External Research Program to the Niagen Research Program, Strengthening Position as the Global Leader in NAD+ Science
- Niagen Bioscience (NAGE) PT Lowered to $11 at H.C. Wainwright
- Niagen Bioscience Announces Participation in Upcoming Investor Conferences
- Niagen Bioscience, Inc. (NAGE) Misses Q1 EPS by 1c, offers outlook
- Form 8-K Niagen Bioscience, Inc. For: May 06
- Niagen Bioscience, Inc. Reports First Quarter 2026 Financial Results
- Form 10-Q Niagen Bioscience, Inc. For: Mar 31
- Niagen Bioscience launches telehealth platform with at-home injection kit
Entities mentioned with NAGE
- FDA | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- H.C. Wainwright | View Related Stories »
- Stock Buyback | View Related Stories »
- Show More...
